FundedIQ
Biotechnology

SonoThera: Funding, Investors & Team (Oct 2026)

SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission is to develop genetic medicines that treat the root cause of human disease. SonoThera is expanding the possibilities of disease treatment with ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments. It aims to improve the lives and health of millions of people.

sonothera.com LinkedIn San Francisco, United States 11-50 employees
Biopharma Biotechnology Genetics Medical B2C
Total raised
$186M
Rounds
2
Latest
Series B
Jun 2026

SonoThera has raised $186M across 2 funding rounds on record, the most recent a Series B of $125M announced in Jun 2026.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

SonoThera Company Profile and Key Stats

Total funding raised
$186M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series B
$125M in Jun 2026
Employees
11-50
reported band
Headquarters
San Francisco, United States

Latest funding round on record: Jun 2026.

SonoThera Funding Rounds

Date
Round
Amount
Series B
$125M
Series A
$60.8M

SonoThera raised $60.8M in a Series A announced in Dec 2022.

3.5 years later, a Series B of $125M was announced in Jun 2026.

SonoThera Founders and Leadership Team

Name
Role
Contact
Kenneth Greenberg
CEO
—

No contact details are on record for this team yet.

SonoThera Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
4,422
$32M

SonoThera's latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like SonoThera in Biotechnology and San Francisco

Companies Similar to SonoThera

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

SonoThera Funding FAQs

What does SonoThera do?

SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission is to develop genetic medicines that treat the root cause of human disease. SonoThera is expanding the possibilities of disease treatment with ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments. It aims to improve the lives and health of millions of people.

How much funding has SonoThera raised?

SonoThera has raised $186M across 2 rounds on record. The most recent is a Series B of $125M announced in Jun 2026.

When did SonoThera last raise funding?

SonoThera's most recent funding round on record is a Series B of $125M, announced in Jun 2026.

Who is the CEO of SonoThera?

Kenneth Greenberg is listed as CEO at SonoThera.

Where is SonoThera headquartered?

SonoThera is based in San Francisco, California, United States.

How many employees does SonoThera have?

SonoThera is in the 11-50 employee band.

How does SonoThera's funding compare to other Biotechnology startups?

SonoThera's latest round of $125M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's SonoThera Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SonoThera is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.